InvestSMART

Elixinol Wellness Limited (ASX: EXL) - Announcements

- Current share price for EXL : $0.006

ASX company news and announcements for Elixinol Wellness Limited (EXL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Elixinol Wellness Limited (EXL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Elixinol Wellness Limited (EXL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Elixinol Wellness Limited (EXL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 The Healthy Chef expands into Priceline 15 May 2026 9:05AM $0.007 $0.006 fallen by 14.29%
$3 Notice of Annual General Meeting/Proxy Form 24 Apr 2026 2:42PM $0.008 $0.006 fallen by 25%
$3 Quarterly Activities/Appendix 4C Cash Flow Report 21 Apr 2026 1:53PM $0.008 $0.006 fallen by 20%
$3 Small Parcel Sale Facility 20 Apr 2026 5:33PM $0.007 $0.006 fallen by 14.29%
$3 Change of Company Secretary 14 Apr 2026 9:26AM $0.007 $0.006 fallen by 14.29%
$3 Date of AGM and Closing Date for Director Nominations 31 Mar 2026 9:47AM $0.007 $0.006 fallen by 14.29%
$3 Change of Share Registrar 30 Mar 2026 12:30PM $0.007 $0.006 fallen by 14.29%
$3 Updated Appendix 3Y - Gavin Evans 10 Mar 2026 4:41PM $0.008 $0.006 fallen by 25%
$3 Repositioned for Sustainable Growth and Margin Expansion 27 Feb 2026 2:33PM $0.009 $0.006 fallen by 33.33%
$3 FY25 Results Investor Presentation 27 Feb 2026 2:32PM $0.009 $0.006 fallen by 33.33%
$3 Appendix 4G and Corporate Governance Statement 27 Feb 2026 2:32PM $0.009 $0.006 fallen by 33.33%
$3 FY25 Appendix 4E and Annual Report 27 Feb 2026 2:31PM $0.009 $0.006 fallen by 33.33%
$3 EXL Updated Investor Presentation - Q4FY25 Results & Outlook 12 Feb 2026 9:39AM $0.009 $0.006 fallen by 33.33%
$3 Q4 FY25 Results & Outlook - Notification of Webinar 10 Feb 2026 9:52AM $0.010 $0.006 fallen by 40%
$3 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jan 2026 10:02AM $0.011 $0.006 fallen by 45.45%
$3 Notification of cessation of securities - EXL 15 Jan 2026 8:22PM $0.011 $0.006 fallen by 45.45%
$3 Appendix 3Y - Gavin Evans 2 Jan 2026 10:05AM $0.009 $0.006 fallen by 33.33%
$3 Change of Auditor 19 Dec 2025 11:22AM $0.011 $0.006 fallen by 45.45%
$3 Revised Healthy Chef Terms Strengthen Elixinol's Position 18 Dec 2025 9:49AM $0.009 $0.006 fallen by 33.33%
$3 Options Exp 23 Oct 2027 Range of Units and Top 20 Holders 9 Dec 2025 12:29PM $0.010 $0.006 fallen by 40%
$3 Application for quotation of securities - EXL 9 Dec 2025 12:25PM $0.010 $0.006 fallen by 40%
$3 Initial Directors Interest Notice - Gavin Evans 9 Dec 2025 9:52AM $0.011 $0.006 fallen by 45.45%
$3 Notification regarding unquoted securities - EXL 8 Dec 2025 9:51AM $0.011 $0.006 fallen by 45.45%
$3 Final Director's Interest Notice - David Fenlon 4 Dec 2025 3:16PM $0.010 $0.006 fallen by 40%
$3 Director Resignation and Appointment of New Chair 2 Dec 2025 4:44PM $0.010 $0.006 fallen by 40%

26 - 50 of 684 results

Page 2 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.